CytomX Therapeutics, Inc.

Historical 13F Holders

Symbol
CTMX
CUSIP
23284F105
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 34 12.2 M $7.98 M
2024 Q4 73 46.7 M $48.1 M
2024 Q3 74 51.2 M $60.4 M
2024 Q2 81 50.9 M $62.1 M
2024 Q1 96 46.3 M $101 M
2023 Q4 73 32.7 M $50.7 M
2023 Q3 65 32.4 M $41.8 M
2023 Q2 70 34.1 M $58.7 M
2023 Q1 81 35.9 M $54.2 M
2022 Q4 86 36.2 M $57.9 M
2022 Q3 85 36.3 M $52.6 M
2022 Q2 100 45.6 M $83.4 M
2022 Q1 126 53.9 M $144 M
2021 Q4 119 54.8 M $237 M
2021 Q3 117 54.0 M $275 M
2021 Q2 129 58.3 M $370 M
2021 Q1 136 56.8 M $439 M
2020 Q4 134 38.6 M $253 M
2020 Q3 136 36.8 M $245 M
2020 Q2 140 37.8 M $315 M
2020 Q1 121 38.9 M $298 M
2019 Q4 123 36.7 M $305 M
2019 Q3 117 35.9 M $265 M
2019 Q2 113 35.8 M $401 M
2019 Q1 119 37.1 M $400 M
2018 Q4 117 38.3 M $579 M
2018 Q3 131 38.3 M $708 M
2018 Q2 150 32.5 M $741 M
2018 Q1 146 29.8 M $846 M
2017 Q4 121 30.1 M $637 M
2017 Q3 98 24.3 M $442 M
2017 Q2 90 22.1 M $343 M
2017 Q1 88 19.3 M $333 M
2016 Q4 70 16.9 M $186 M
2016 Q3 62 19.7 M $309 M
2016 Q2 60 18.8 M $193 M
2016 Q1 49 17.7 M $228 M
2015 Q4 49 17.4 M $360 M